GRAIL, Inc. (GRAL) stock
GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$102.10−3.78 (-3.57%)
Close on Nov 18, 2026Market cap $4.56BP/E –Yield –
Grail operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Grail's operating income for the twelve months ending Jun 30, 2026 was -$559.25M. For fiscal 2025 it was -$562.16M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$562.16M | – |
| FY2024 | Dec 31, 2024 | -$2.19B | – |
| FY2023 | Dec 31, 2023 | -$1.52B | – |
| FY2022 | Jan 1, 2023 | -$5.44B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$173.78M | – |
| Q1 FY2026 | Mar 31, 2026 | -$135.77M | – |
| Q4 FY2025 | Dec 31, 2025 | -$124.41M | – |
| Q3 FY2025 | Sep 30, 2025 | -$125.29M | – |
| Q2 FY2025 | Jun 30, 2025 | -$158.85M | – |
| Q1 FY2025 | Mar 31, 2025 | -$153.61M | – |
| Q4 FY2024 | Dec 31, 2024 | -$136.94M | – |
| Q3 FY2024 | Sep 30, 2024 | -$183.51M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.64B | – |
| Q1 FY2024 | Mar 31, 2024 | -$227.42M | – |
| Q4 FY2023 | Dec 31, 2023 | -$194.59M | – |
| Q3 FY2023 | Oct 1, 2023 | -$912.39M | – |
| Q2 FY2023 | Jun 30, 2023 | -$204.37M | – |
See a number that looks wrong?